337 related articles for article (PubMed ID: 26614904)
1. Hairy cell leukaemia-variant: Disease features and treatment.
Matutes E; Martínez-Trillos A; Campo E
Best Pract Res Clin Haematol; 2015 Dec; 28(4):253-63. PubMed ID: 26614904
[TBL] [Abstract][Full Text] [Related]
2. The variant form of hairy-cell leukaemia.
Matutes E; Wotherspoon A; Catovsky D
Best Pract Res Clin Haematol; 2003 Mar; 16(1):41-56. PubMed ID: 12670464
[TBL] [Abstract][Full Text] [Related]
3. Hairy cell leukemia-variant--a case report.
Gupta K; Jasmina A; Malhotra P; Varma N; Vaiphei K; Vohra H; Varma S; Garewal G
Indian J Pathol Microbiol; 2005 Jul; 48(3):387-9. PubMed ID: 16761764
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow and splenic histology in hairy cell leukaemia.
Wotherspoon A; Attygalle A; Mendes LS
Best Pract Res Clin Haematol; 2015 Dec; 28(4):200-7. PubMed ID: 26614898
[TBL] [Abstract][Full Text] [Related]
5. Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.
Cornet E; Delmer A; Feugier P; Garnache-Ottou F; Ghez D; Leblond V; Levy V; Maloisel F; Re D; Zini JM; Troussard X;
Ann Hematol; 2014 Dec; 93(12):1977-83. PubMed ID: 24994538
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and molecular characteristics and prognosis of classical hairy cell leukemia and hairy cell leukemia variant].
Wei C; Jin XX; Cai H; Wang X; Zhuang JL; Zhou DB
Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):416-421. PubMed ID: 37032137
[No Abstract] [Full Text] [Related]
7. Long-term follow-up after purine analogue therapy in hairy cell leukaemia.
Else M; Dearden CE; Catovsky D
Best Pract Res Clin Haematol; 2015 Dec; 28(4):217-29. PubMed ID: 26614900
[TBL] [Abstract][Full Text] [Related]
8. Polyclonal B-cell lymphocytosis with features resembling hairy cell leukemia-Japanese variant.
Machii T; Yamaguchi M; Inoue R; Tokumine Y; Kuratsune H; Nagai H; Fukuda S; Furuyama K; Yamada O; Yahata Y; Kitani T
Blood; 1997 Mar; 89(6):2008-14. PubMed ID: 9058722
[TBL] [Abstract][Full Text] [Related]
9. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment.
Maitre E; Cornet E; Troussard X
Am J Hematol; 2019 Dec; 94(12):1413-1422. PubMed ID: 31591741
[TBL] [Abstract][Full Text] [Related]
10. A case of hairy cell leukemia variant.
Găman AM; Dobrea CM; Găman MA
Rom J Morphol Embryol; 2015; 56(2):553-6. PubMed ID: 26193228
[TBL] [Abstract][Full Text] [Related]
11. Rituximab in the treatment of the variant of hairy cell leukaemia: a case report.
Hadzi-Pecova L; Stojanovik A; Petrusevska G; Panovska I
Prilozi; 2008 Dec; 29(2):355-60. PubMed ID: 19259059
[TBL] [Abstract][Full Text] [Related]
12. Hairy cell leukemia and variant in Taiwan: report of a variant case and literature review.
Hsieh YC; Chang ST; Chuang SS; Lu CL; Tsao CJ; Lin CN; Li CY
Int J Clin Exp Pathol; 2011 Jan; 4(2):183-9. PubMed ID: 21326814
[TBL] [Abstract][Full Text] [Related]
13. VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.
Arons E; Suntum T; Stetler-Stevenson M; Kreitman RJ
Blood; 2009 Nov; 114(21):4687-95. PubMed ID: 19745070
[TBL] [Abstract][Full Text] [Related]
14. CD103-CD23+ classical hair cell leukemia: A case report and review of the literature.
Zhao HL; Cui HH; Jin LF; Zhao M; Shen WZ
Medicine (Baltimore); 2021 Dec; 100(51):e28262. PubMed ID: 34941102
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic and molecular features in hairy cell leukemia-variant: single institutional experience.
Angelova EA; Medeiros LJ; Wang W; Muzzafar T; Lu X; Khoury JD; Ravandi F; Patel KP; Hu Z; Kanagal-Shamanna R
Mod Pathol; 2018 Nov; 31(11):1717-1732. PubMed ID: 29955146
[TBL] [Abstract][Full Text] [Related]
16. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept.
Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J
Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628
[TBL] [Abstract][Full Text] [Related]
17. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
Yang MH; Ho CH
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
[TBL] [Abstract][Full Text] [Related]
18. [Hairy cell leukemia, Japanese variant, successfully treated with cladribine].
Miyazaki M; Taguchi A; Sakuragi S; Mitani N; Matsuda K; Shinohara K
Rinsho Ketsueki; 2004 May; 45(5):405-7. PubMed ID: 15199752
[TBL] [Abstract][Full Text] [Related]
19. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia].
Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031
[TBL] [Abstract][Full Text] [Related]
20. Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior.
Forconi F; Sozzi E; Cencini E; Zaja F; Intermesoli T; Stelitano C; Rigacci L; Gherlinzoni F; Cantaffa R; Baraldi A; Gallamini A; Zaccaria A; Pulsoni A; Gobbi M; Tassi M; Raspadori D; Leoncini L; Rinaldi A; Sabattini E; Bertoni F; Pileri SA; Lauria F
Blood; 2009 Nov; 114(21):4696-702. PubMed ID: 19667403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]